Louise Brackenbury, PhD

Louise received her PhD in viral immunology from UCL, prior to two post-doctoral fellowships at Imperial College and Bristol University. Louise joined KWS BioTest in 2012, then Charles River in 2018 following acquisition of the Portishead, UK site, where she led an Immune Cell Biology Group as a Group Leader. In 2021 she moved to the role of Associate Director of Innovation at the site, leading a group of Research Leaders with the remit to develop translationally relevant models and deliver cutting edge science to support drug discovery programs. In 2022 she became Science Director, working across all divisions and therapeutic areas to support scientific growth at the site. She is now the Science Director, Advanced Modalities. With expertise in immunology and cell biology, she has developed a wide range of immunology-focused assays and models, spanning immuno-oncology, autoimmunity, the microbiome, and inflammation.